PUBLISHER: Lucintel | PRODUCT CODE: 1416296
PUBLISHER: Lucintel | PRODUCT CODE: 1416296
The future of the global therapeutic respiratory device market looks promising with opportunities in the nebulizer filter, humidifier filter, positive airway pressure devices filter, oxygen concentrator filter, and ventilator filter markets. The global therapeutic respiratory device market is expected to grow with a CAGR of 9.2% from 2024 to 2030. The major drivers for this market are growing prevalance of respiratory diseases, changing lifestyles, and increasing air polutions.
A more than 150-page report is developed to help in your business decisions.
The study includes a forecast for the global therapeutic respiratory device by product type, technology, filter, and region.
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies therapeutic respiratory device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the therapeutic respiratory device companies profiled in this report include-
Lucintel forecasts that oxygen concentrators will remain the largest segment over the forecast period due to rising demand for home oxygen therapy and growing cases of respiratory diseases.
Within this market, humidifier filters is expected to witness the highest growth due to growing usage in households, healthcare institutions, hospitals, and schools.
North America will remain the largest region over the forecast period due to favorable reimbursement policies and growing cases of COPD, pneumonia, and asthma in the region.
Market Size Estimates: Therapeutic respiratory device market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Therapeutic respiratory device market size by product type, technology, filter, and region in terms of value ($B).
Regional Analysis: Therapeutic respiratory device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product types, technologies, filters, and regions for the therapeutic respiratory device market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the therapeutic respiratory device market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
Q1. What is the growth forecast for therapeutic respiratory device market?
Answer: The global therapeutic respiratory device market is expected to grow with a CAGR of 9.2% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the therapeutic respiratory device market?
Answer: The major drivers for this market are growing prevalance of respiratory diseases, changing lifestyles and increasing air polutions.
Q3. What are the major segments for therapeutic respiratory device market?
Answer: The future of the therapeutic respiratory device market looks promising with opportunities in the nebulizer filter, humidifier filter, positive airway pressure devices filter, oxygen concentrator filter, and ventilator filter markets.
Q4. Who are the key therapeutic respiratory device market companies?
Answer: Some of the key therapeutic respiratory device companies are as follows:
Q5. Which therapeutic respiratory device market segment will be the largest in future?
Answer: Lucintel forecasts that oxygen concentrators will remain the largest segment over the forecast period due to rising demand for home oxygen therapy and growing cases of respiratory diseases.
Q6. In therapeutic respiratory device market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to favorable reimbursement policies and growing cases of COPD, pneumonia, and asthma in the region.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.